Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Hypertonic Xylitol vs Hypertonic Saline in Cystic Fibrosis
NCT01355796Phase 2Completed
- Start
- May 2011
- Primary completion
- Feb 2015
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of xylitol in cystic fibrosis (CF) (2 arms). Primary endpoint: Change in FEV1 % Predicted From Baseline at 14 days. Started May 2011; status: completed.
02
Drugs
xylitol
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01355796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01355796.